openPR Logo
Press release

Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs

11-20-2018 09:10 AM CET | Health & Medicine

Press release from: Mordor Intelligence

Mordor Intelligence

Mordor Intelligence

On the occasion of World Diabetes Awareness Month, Mordor Intelligence reiterated its commitment to helping enterprises in the business of Diabetes Care Drugs by enabling them to make smart strategic decisions. The company has announced that it is offering a full access to its Intelligence Center on the Diabetes Care Drugs for FREE. With the successful launch of this Intelligence Center last month, Mordor is already ensuring that the benefits of this data reaches all possible enterprises in this space.

The data put together by Mordor Intelligence greatly strengthens the medical community's continuous research on understanding Diabetes and the drugs used in its treatment. This market intelligence data greatly benefits enterprises in making the right decisions, by helping foster a clear understanding of the various industry trends. The company is allowing enterprises FULL ACCESS to this exhaustive and precise data related to diabetes.

This limited time Free access can be set up here: https://www.mordorintelligence.com/free-trial/diabetes-care-market

Mordor's Intelligence Center on the Diabetes Care Drugs Market offers extensive and precise data spanning 15 segments under 4 categories, covering 25 countries from 5 regions. This data is additionally backed by the brand share information of 33 brands with an R&D pipeline. A key differentiator of this platform in comparison to similar services is the accuracy and timeliness of the data. This Intelligence Center is updated every quarter with significant changes reflecting real-time information. In addition, the platform is extremely user-friendly and offers a seamless, intuitive experience. In addition to Intelligence on Diabetes Care Drugs, Mordor also offers a comprehensive Intelligence Center on Diabetes Care Devices.

The coverage offered is as listed:

CATEGORIES & SEGMENTS

Insulin
Basal Insulin
Bolus Insulin
Human Insulin
Human Insulin Inhaled
Non-Insulin Injectables
Amylin Analogue
GLP-1 Agonist
Oral Antidiabetic Drugs
Alpha Glucosidase Inhibitors
Biguanides
Dopamine - B2 receptor agonist
DPP-4 Inhibitors
Meglitinide
SGLT-2 Inhibitors
Sulfonylureas
Combination Drugs
Insulin Combination
Oral Combination

REGIONS & COUNTRIES

Asia Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
South Korea
Thailand
Vietnam
Europe
France
Germany
Italy
Russia
Spain
United Kingdom
Latin America
Brazil
Mexico
North America
Canada
United States
Middle East
Egypt
Iran
Oman
Saudi Arabia
South Africa

BRANDS

Afrezza
Apidra
Basaglar
Bydureon
Byetta
Cycloset
Farxiga/Forxiga
Galvus
Generic
Humalog
Humulin
Insuman
Invokana
Janumet
Januvia
Jardiance
Lantus
Levemir
Lyxumia
Novolin/Human Insulin
Novolog/NovoRapid
NovoMix
Onglyza
Ryzodeg
Suglat
Symlin
Toujeo
Tradjenta
Tresiba
Trulicity
Victoza
Vipidia/Nesina
Xultophy

Mordor Intelligence, LLP. operates in the business of industry analysis & consulting, helping clients shape their strategic decisions. Founded in 2013, and fully revenue-funded, Mordor is based out of Hyderabad, India. The company offers custom market intelligence and advisory services along with syndicated reports to help customers gain the edge over the competition. Mordor caters to over 500 clients across the globe in various industries. (www.mordorintelligence.com)

MEDIA CONTACT

Name: Sameeksha Bansal
Email: sameeksha@mordorintelligence.com
Phone: +1-617-765-2493

Address- Mordor Intelligence
Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs here

News-ID: 1377096 • Views: 553

More Releases from Mordor Intelligence

Animal Feed Additives Market Size to Reach $37 Billion by 2022
CP Group, Cargill, New Hope Liuhe, ForFarmers NV, East Hope Group, and Nutreco happily coexist amid steady growth in the Global Feed Additives Market. The Global Feed Additives Market was valued at $28.6 Billion in 2016 and is estimated to reach $37 Billion by 2022 registering a CAGR of 7.03% over this period as per a report by Mordor Intelligence, a market intelligence firm. Feed additives are essential in animal nutrition,
Microbial Pesticide Market
Valent BioSciences, Certis, BioWorks, Morrone BioInnovations, among others, Coexist in the Global Microbial Pesticide Market The Global Microbial Pesticide market was valued at USD 1,388.55 million in the year 2015, and it is projected to record a CAGR of 12.51% in the forecast period to reach a value of USD 3,075.88 million by 2022. Latest Developments Crop protection multinationals have shown a lot of interest in the bio-control industry, giving the highest
Die Casting Lubricants Market
Technological advancements have led to the development of highly engineered die lubricants that can be tailored to enhance the die-casting process, allowing them to gain additional efficiency. The market is expected to grow at a CAGR of 9.50% and touch USD 1.45 billion by the end of the forecast period. Die lubricants provide their effectiveness where they can be engineered to optimize wetting and spreading times, promote metal flow, quickly
Global Managed Services Market 2017- Forecast to 2022
The Global managed services market is estimated to be USD 155.66 billion in 2016, and it is projected to reach USD 252.97 billion, at a CAGR of 10.20% during the forecast period (2017 — 2022). Managed services can be classified into Application Service Providers (ASPs) and Managed Service Providers (MSPs). ASPs include the vendors that deal in telecommunication equipment, along with value-added managed services. MSPs, on the other hand, collaborate

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in